Skip to main content

Advertisement

Table 2 Concentration of low molecular weight urinary proteins in T2DM patients with and without secondary complications

From: Characterization of low molecular weight urinary proteins at varying time intervals in type 2 diabetes mellitus and diabetic nephropathy patients

Molecular weight in kDa Control (mg/dl) T2DM with 0–5 years (mg/dl) T2DM with 5–10 years (mg/dl) T2DM with 10–15 years (mg/dl) T2DM with 15–20 years (mg/dl) Micro albuminuria (mg/dl) Diabetic nephropathy (mg/dl) Non diabetic nephropathy (mg/dl)
13 1.5 3.01 NSa 12.37 ***ab 18.11 ***abc 26.82 ***abcd 99.93 ***abc,NSe 318.54 ***abcdef 0.67 NSabcdefg
17 1.32 34.38 ***a 32.89 ***aNSb 32.62 ***aNSbc 37.64 ***aNSbcd 175.92 ***abcde 217.48 **abcdef 0 NSabcdefg
23 15.42 15.42 NSa 16.76 NSab 17.81 NSabc 33.87 *aNSbcd 76.15 ***abcd **e 158.39 *abcdef 0.32 NSabcdefg
24 2.42 5.42 NSa 7.69 NSab 7.88 NSabc 12.7 ***a *bcd 51.29 ***abcde 71.32 ***abcdef 0 NSabcdefg
28 7.21 7.21 Nsa 7.56 NSab 9.63 NSabc 13.28 *abcNSd 109.35 ***abcde 71.83 ***abcdef 0.11 Nsabcdefg
35 1.94 3.65 Nsa 4.21 NSab 5.6 NSabc 6.44 NSabcd 45.68 ***abcde 52.09 ***abcdef 0 Nsabcdefg
37 1.25 7.52 *a 7.86 *aNSb 8.21 *aNSbc 12.23 ***a *bcd 45.73 ***abcde 69.43 ***abcdef 0 NSabcdefg
39 0.09 2.11 NSa 2.2 NSab 2.45 NSabc 3.05 NSabcd 28.97 ***abcde 41.83 ***abcdef 0 NSabcdefg
41 8.48 22.15 **a 23.14 **aNSb 26.71 **aNSbc 26.24 **aNSbcd 149.25 ***abcde 246.93 ***abcdef 0 NSabcdefg
49 11.28 23.61 *a 23 *aNSb 23.57 *aNSbc 32.76 **a *bcd 214.62 ***abcde 341.59 **abcdef 0.14 NSabcdefg
50 8.72 31.03 **a 31.5 **aNSb 32.6 **aNSbc 33.02 **aNSbcd 172.18 ***abcde 216.61 **abcdef 0 NSabcdefg
  1. The results are expressed as mean + SE and p < 0.05 is considered significant. * p < 0.05, ** p < 0.001, *** p < 0.0001
  2. a—compared with control, b—compared with 0–5 years, T2DM, c—compared with 5–10 years T2DM, d—compared with 10–15 years T2DM, e—compared with 15–20 years T2DM, f—compared with microalbuminuria, g—compared with diabetic nephropathy
  3. NS, non significant